ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p766.xmlNext-Generation Cancer Vaccine Approaches: Integrating Lessons Learned From Current Successes With Promising Biotechnologic Advances2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p766.pdf2026-04-18Next-Generation Cancer Vaccine Approaches: Integrating Lessons Learned From Current Successes With Promising Biotechnologic Advanceshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p753.xmlBreast Cancer, Version 3.20132026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p753.pdf2026-04-18Breast Cancer, Version 3.2013https://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p745.xmlAn Unusual Presentation of Chronic Myelogenous Leukemia: A Review of Isolated Central Nervous System Relapse2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p745.pdf2026-04-18An Unusual Presentation of Chronic Myelogenous Leukemia: A Review of Isolated Central Nervous System Relapsehttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p743.xmlPractice Patterns and Guidelines-Based Treatments: A Renewed Call for Papers on Excellence in Cancer Care in Changing Times2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p743.pdf2026-04-18Practice Patterns and Guidelines-Based Treatments: A Renewed Call for Papers on Excellence in Cancer Care in Changing Timeshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-pxxxvi.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-pxxxvi.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p793.xmlOptimizing Systemic Therapy for Bladder Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p793.pdf2026-04-18Optimizing Systemic Therapy for Bladder Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-pxxiv.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-pxxiv.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-pxxxii.xmlNCCN Guidelines® Updates2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-pxxxii.pdf2026-04-18NCCN Guidelines® Updateshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p780.xmlSystemic Therapy for Small Cell Lung Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p780.pdf2026-04-18Systemic Therapy for Small Cell Lung Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p838.xmlMyelodysplastic Syndromes2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p838.pdf2026-04-18Myelodysplastic Syndromeshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p877.xmlThe Multifaceted Nature of Myelodysplastic Syndromes: Clinical, Molecular, and Biological Prognostic Features2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p877.pdf2026-04-18The Multifaceted Nature of Myelodysplastic Syndromes: Clinical, Molecular, and Biological Prognostic Featureshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p892.xmlCutting Edge: Flow Cytometry in Myelodysplastic Syndromes2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p892.pdf2026-04-18Cutting Edge: Flow Cytometry in Myelodysplastic Syndromeshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p812.xmlGleason Scoring at a Comprehensive Cancer Center: What’s The Difference?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p812.pdf2026-04-18Gleason Scoring at a Comprehensive Cancer Center: What’s The Difference?https://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p827.xmlThe Case for Including Bowel Urgency in Toxicity Reporting After Pelvic Cancer Treatment2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p827.pdf2026-04-18The Case for Including Bowel Urgency in Toxicity Reporting After Pelvic Cancer Treatmenthttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p904.xmlAre Centers and Practices Implementing Changes to Their Reimbursement or Payment Models? An NCCN Trends Report2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/7/article-p904.pdf2026-04-18Are Centers and Practices Implementing Changes to Their Reimbursement or Payment Models? An NCCN Trends Report